Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Namisol for persistent abdominal pain in chronic pancreatitis
2012-000730-19Phase 2Terminated
- Sponsor
- Radboud University Medical Center
- Start
- Mar 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of sodium oxybate in chronic pancreatitis (CP) (2 arms), sponsored by Radboud University Medical Center. Primary endpoint: Pain intensity. Started Mar 2012; status: terminated.
02
Drugs
sodium oxybate
03
Conditions
chronic pancreatitis (CP)
Beyond the preview
Go deeper on 2012-000730-19.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-000730-19.